Remed Co.,Ltd. (KOSDAQ: 302550)

Market Cap	89.31B
Revenue (ttm)	21.56B
Net Income (ttm)	2.36B
Shares Out	30.64M
EPS (ttm)	76.94
PE Ratio	37.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,197
Open	2,910.00
Previous Close	2,900.00
Day's Range	2,865.00 - 2,945.00
52-Week Range	2,545.00 - 21,400.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Remed Co.,Ltd.

Remed Co.,Ltd. engages in the manufactures and supplies of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as tinnitus, insomnia, dementia, stress, anxiety, etc. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides e...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2003
• Employees: 90
• Stock Exchange: KOSDAQ
• Ticker Symbol: 302550

Financial Performance

In 2023, Remed Co.,Ltd.'s revenue was 18.54 billion, a decrease of -13.23% compared to the previous year's 21.36 billion. Earnings were 797.17 million, a decrease of -80.07%.